BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15584861)

  • 41. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y; Uegaki K; Kigawa J; Terakawa N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract]   [Full Text] [Related]  

  • 44. Redox regulation of PI 3-kinase signalling via inactivation of PTEN.
    Leslie NR; Bennett D; Lindsay YE; Stewart H; Gray A; Downes CP
    EMBO J; 2003 Oct; 22(20):5501-10. PubMed ID: 14532122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids.
    McConnachie G; Pass I; Walker SM; Downes CP
    Biochem J; 2003 May; 371(Pt 3):947-55. PubMed ID: 12534371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of novel intracellular agonist responsive pools of phosphatidylinositol 3,4-bisphosphate using the TAPP1 pleckstrin homology domain in immunoelectron microscopy.
    Watt SA; Kimber WA; Fleming IN; Leslie NR; Downes CP; Lucocq JM
    Biochem J; 2004 Feb; 377(Pt 3):653-63. PubMed ID: 14604433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1.
    Fox JA; Ung K; Tanlimco SG; Jirik FR
    J Immunol; 2002 Jul; 169(1):49-54. PubMed ID: 12077227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PTEN and cancer.
    Parsons R; Simpson L
    Methods Mol Biol; 2003; 222():147-66. PubMed ID: 12710685
    [No Abstract]   [Full Text] [Related]  

  • 49. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.
    Scharenberg AM; El-Hillal O; Fruman DA; Beitz LO; Li Z; Lin S; Gout I; Cantley LC; Rawlings DJ; Kinet JP
    EMBO J; 1998 Apr; 17(7):1961-72. PubMed ID: 9524119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate.
    Campbell RB; Liu F; Ross AH
    J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.
    Ge NL; Rudikoff S
    Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
    Soussi T
    Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolic switching of PI3K-dependent lipid signals.
    Downes CP; Leslie NR; Batty IH; van der Kaay J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):188-92. PubMed ID: 17371235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [PTEN tumor suppressor: functions as a lipid phosphatase].
    Maehama T; Dixon JE
    Tanpakushitsu Kakusan Koso; 2000 Oct; 45(14):2405-14. PubMed ID: 11051842
    [No Abstract]   [Full Text] [Related]  

  • 57. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
    Unoki M; Nakamura Y
    Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural assets of a tumor suppressor.
    Tonks NK; Myers MP
    Science; 1999 Dec; 286(5447):2096-7. PubMed ID: 10617421
    [No Abstract]   [Full Text] [Related]  

  • 59. Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling.
    Testai FD; Landek MA; Goswami R; Ahmed M; Dawson G
    J Neurochem; 2004 May; 89(3):636-44. PubMed ID: 15086520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
    Rouault JP; Kuwabara PE; Sinilnikova OM; Duret L; Thierry-Mieg D; Billaud M
    Curr Biol; 1999 Mar; 9(6):329-32. PubMed ID: 10209098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.